Close
ACHEMA MIDDLE EAST 2026

Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment

Pfizer Inc. and Sangamo Therapeutics, Inc., a genomic medicines company, announced that the first participant has been dosed in the Phase 3 AFFINE study...

Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom

Novavax, Inc. , a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that it has initiated its first Phase 3...

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by...

Boehringer, Mirati Therapeutics Enter Clinical Collaboration

Boehringer Ingelheim and Mirati Therapeutics, Inc. entered a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor, and MRTX849, a KRAS...

Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans, Maryland

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

India’s top drug regulator– Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and...

Natoli NP-RD30 Included at Diosna ProcessLab

The Diosna Dierks & Söhne GmbH recently opened the “Diosna ProcessLab” located in Osnabrück, Germany. The lab, which was completed in April 2020, offers...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...